清醒俯卧位通气对COVID-19合并急性呼吸衰竭患者气管插管的影响:一项随机临床试验
该实用、非盲法随机临床试验在加拿大、科威特、沙特阿拉伯和美国的21家医院纳入400例未插管但需氧疗(≥40%)或无创通气的COVID-19成人患者,随机分为清醒俯卧位组(n=205)和常规护理组(n=195)。结果显示,俯卧位未显著降低30天内气管插管率(34.1% vs 40.5%,HR 0.81,95%CI 0.59-1.12,P=0.20),也未显著改善60天死亡率等次要结局,但效应量不精确,不能排除临床重要获益。
要点
- 清醒俯卧位未显著降低30天气管插管率(34.1% vs 40.5%,HR 0.81,95%CI 0.59-1.12,P=0.20)。
- 俯卧位未显著降低60天死亡率(HR 0.93,95%CI 0.62-1.40,P=0.54)。
- 俯卧位组10%患者出现不良事件,最常见为肌肉骨骼疼痛或不适(6.34%)和血氧饱和度下降(0.98%)。
核心结论
- 在COVID-19所致急性低氧性呼吸衰竭患者中,与未采用俯卧位的常规护理相比,俯卧位未显著降低30天内气管插管率。
- 主要结局的效应量不精确,不能排除临床重要获益。
研究设计与样本
- 实用、非盲法随机临床试验,在加拿大、科威特、沙特阿拉伯和美国的21家医院进行。
- 纳入400例未插管且需要氧疗(≥40%)或无创通气的COVID-19成人患者,2020年5月19日至2021年5月18日入组,最终随访于2021年7月完成。
- 患者随机分为清醒俯卧位组(n=205)和未采用俯卧位的常规护理组(对照组,n=195)。
主要发现
- 随机化后前4天,俯卧位组中位俯卧位时间为4.8小时/天(IQR 1.8-8.0),对照组为0小时/天(IQR 0-0)。
- 30天内俯卧位组205例中70例(34.1%)插管,对照组195例中79例(40.5%)插管(HR 0.81,95%CI 0.59-1.12,P=0.20;绝对差异-6.37%,95%CI -15.83%至3.10%)。
- 俯卧位未显著降低60天死亡率(HR 0.93,95%CI 0.62-1.40,P=0.54;绝对差异-1.15%,95%CI -9.40%至7.10%)。
- 俯卧位对30天无创通气或无创通气无天数及60天无ICU或住院天数无显著影响。
- 两组均无严重不良事件;俯卧位组21例(10%)发生不良事件,最常见为俯卧位相关肌肉骨骼疼痛或不适(205例中13例,6.34%)和血氧饱和度下降(205例中2例,0.98%);对照组未报告不良事件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出主要结局的效应量不精确,不能排除临床重要获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The efficacy and safety of prone positioning is unclear in nonintubated patients with acute hypoxemia and COVID-19. OBJECTIVE: To evaluate the efficacy and adverse events of prone positioning in nonintubated adult patients with acute hypoxemia and COVID-19. DESIGN, SETTING, AND PARTICIPANTS: Pragmatic, unblinded randomized clinical trial conducted at 21 hospitals in Canada, Kuwait, Saudi Arabia, and the US. Eligible adult patients with COVID-19 were not intubated and required oxygen (≥40%) or noninvasive ventilation. A total of 400 patients were enrolled between May 19, 2020, and May 18, 2021, and final follow-up was completed in July 2021. INTERVENTION: Patients were randomized to awake prone positioning (n = 205) or usual care without prone positioning (control; n = 195). MAIN OUTCOMES AND MEASURES: The primary outcome was endotracheal intubation within 30 days of randomization. The secondary outcomes included mortality at 60 days, days free from invasive mechanical ventilation or noninvasive ventilation at 30 days, days free from the intensive care unit or hospital at 60 days, adverse events, and serious adverse events. RESULTS: Among the 400 patients who were randomized (mean age, 57.6 years [SD, 12.83 years]; 117 [29.3%] were women), all (100%) completed the trial. In the first 4 days after randomization, the median duration of prone positioning was 4.8 h/d (IQR, 1.8 to 8.0 h/d) in the awake prone positioning group vs 0 h/d (IQR, 0 to 0 h/d) in the control group. By day 30, 70 of 205 patients (34.1%) in the prone positioning group were intubated vs 79 of 195 patients (40.5%) in the control group (hazard ratio, 0.81 [95% CI, 0.59 to 1.12], P = .20; absolute difference, -6.37% [95% CI, -15.83% to 3.10%]). Prone positioning did not significantly reduce mortality at 60 days (hazard ratio, 0.93 [95% CI, 0.62 to 1.40], P = .54; absolute difference, -1.15% [95% CI, -9.40% to 7.10%]) and had no significant effect on days free from invasive mechanical ventilation or noninvasive ventilation at 30 days or on days free from the intensive care unit or hospital at 60 days. There were no serious adverse events in either group. In the awake prone positioning group, 21 patients (10%) experienced adverse events and the most frequently reported were musculoskeletal pain or discomfort from prone positioning (13 of 205 patients [6.34%]) and desaturation (2 of 205 patients [0.98%]). There were no reported adverse events in the control group. CONCLUSIONS AND RELEVANCE: In patients with acute hypoxemic respiratory failure from COVID-19, prone positioning, compared with usual care without prone positioning, did not significantly reduce endotracheal intubation at 30 days. However, the effect size for the primary study outcome was imprecise and does not exclude a clinically important benefit. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04350723.
引用
- Alhazzani W, Parhar KKS, Weatherald J, et al. Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial. JAMA. 2022. PMID: 35569448. doi:10.1001/jama.2022.7993
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。